Sort
23,748 grants matching “melanoma”
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
$1,040,468David J. Margolis · University Of Pennsylvania · U01 · FY2021 · AR
Molecular Pathogenesis of Neoplasia
$1,040,298John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
A novel immunotolerizing therapy for autoimmune vitiligo
$1,039,086Kanneganti Murthy · Radikal Therapeutics, Inc. · R44 · FY2017 · AR
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,038,185Glenn T. Merlino · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
High-throughput sequencing to identify novel melanoma susceptibility genes
$1,036,661Chad Daniel Huff · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$1,036,451Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$1,035,240James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$1,035,240James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$1,035,240James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Molecular Response and Imaging-based Combination Strategies for Optimal PDT
$1,035,201Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2020 · CA
Determining the Fate of Transmembrane Proteins
$1,035,009Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Developmental Funds
$1,034,770Charles W Roberts · St. Jude Children'S Research Hospital · P30 · FY2025 · CA
Genomic Sunlight Dosimeters for Melanoma Prevention
$1,033,429Douglas E Brash · Yale University · P50 · FY2015 · CA
CLINICAL INVESTIGATIONS
$1,032,151Massachusetts General Hospital · P01 · FY2000 · CA
CLINICAL TRIALS
$1,032,151Massachusetts General Hospital · P01 · FY2000 · CA
Tumor Microenvironment in Cancer Progression
$1,030,688Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Comparative Biomedical Scientist Training Program
$1,029,500Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2016 · CA
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
$1,029,338David J. Margolis · University Of Pennsylvania · U01 · FY2022 · AR
Determining the Fate of Transmembrane Proteins
$1,028,830Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
MARKERS TO IMPROVE ASSESSMENT OF TREATMENT EFFICACY FOR METASTATIC MELANOMA
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CHARACTERIZATION OF TUMOR ANTIGENS THAT ELICIT HUMORAL IMMUNE RESPONSES IN MAN
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CORE--BIOSTATISTICAL SERVICES
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CORE--SERUM, LYMPHOCYTE AND TISSUE COLLECTION AND ANALYSIS
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CLINICAL INVESTIGATION OF ACTIVE SPECIFIC IMMUNOTHERAPY OF MALIGNANT MELANOMA
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
Integrated, Individualized, Intelligent Prescribing (I3P)
$1,027,757Joshua C. Denny · Vanderbilt University Medical Center · U01 · FY2016 · HG